Latest return on equity
Aspire Biopharma Holdings Return on equity
Direct answer
Aspire Biopharma Holdings's return on equity is -1,032.14%.
The verified market snapshot reports -1,032.14%.
Bullstory displays the reported value and does not estimate missing data.
Market data checked September 6, 2026.
Get free Aspire Biopharma Holdings email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Return on equity
- -1,032.14%